193 related articles for article (PubMed ID: 38034009)
1. A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype.
Torabidastgerdooei S; Roy ME; Annabi B
Front Endocrinol (Lausanne); 2023; 14():1265698. PubMed ID: 38034009
[TBL] [Abstract][Full Text] [Related]
2. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
3. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
Pan CJ; Chen SY; Jun HS; Lin SR; Mansfield BC; Chou JY
PLoS One; 2011; 6(9):e23157. PubMed ID: 21949678
[TBL] [Abstract][Full Text] [Related]
4. The SLC37 family of sugar-phosphate/phosphate exchangers.
Chou JY; Mansfield BC
Curr Top Membr; 2014; 73():357-82. PubMed ID: 24745989
[TBL] [Abstract][Full Text] [Related]
5. The SLC37 family of phosphate-linked sugar phosphate antiporters.
Chou JY; Sik Jun H; Mansfield BC
Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
[TBL] [Abstract][Full Text] [Related]
6. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.
Cappello AR; Curcio R; Lappano R; Maggiolini M; Dolce V
Front Chem; 2018; 6():122. PubMed ID: 29719821
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.
Iwadate Y; Matsutani T; Hirono S; Shinozaki N; Saeki N
J Neurooncol; 2016 Aug; 129(1):101-7. PubMed ID: 27193555
[TBL] [Abstract][Full Text] [Related]
8. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.
Veiga-da-Cunha M; Chevalier N; Stephenne X; Defour JP; Paczia N; Ferster A; Achouri Y; Dewulf JP; Linster CL; Bommer GT; Van Schaftingen E
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1241-1250. PubMed ID: 30626647
[TBL] [Abstract][Full Text] [Related]
9. Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.
Abbadi S; Rodarte JJ; Abutaleb A; Lavell E; Smith CL; Ruff W; Schiller J; Olivi A; Levchenko A; Guerrero-Cazares H; Quinones-Hinojosa A
Mol Cancer Res; 2014 Nov; 12(11):1547-59. PubMed ID: 25001192
[TBL] [Abstract][Full Text] [Related]
10. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β mimics the key proteome properties of CD133
Bryukhovetskiy I; Shevchenko V; Arnotskaya N; Kushnir T; Pak O; Victor Z; Zaitsev S; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS
Int Rev Neurobiol; 2020; 151():219-242. PubMed ID: 32448609
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
13. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
14. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
15. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
[TBL] [Abstract][Full Text] [Related]
16. SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.
Hiwarkar P; Bargir U; Pandrowala A; Bodhanwala M; Thakker N; Taur P; Madkaikar M; Desai M
J Clin Immunol; 2022 Nov; 42(8):1653-1659. PubMed ID: 35838821
[TBL] [Abstract][Full Text] [Related]
17. Post-Translational Regulation of the Glucose-6-Phosphatase Complex by Cyclic Adenosine Monophosphate Is a Crucial Determinant of Endogenous Glucose Production and Is Controlled by the Glucose-6-Phosphate Transporter.
Soty M; Chilloux J; Delalande F; Zitoun C; Bertile F; Mithieux G; Gautier-Stein A
J Proteome Res; 2016 Apr; 15(4):1342-9. PubMed ID: 26958868
[TBL] [Abstract][Full Text] [Related]
18. A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres.
Gresseau L; Roy ME; Duhamel S; Annabi B
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497426
[No Abstract] [Full Text] [Related]
19. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
[TBL] [Abstract][Full Text] [Related]
20. Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.
Boulanger C; Stephenne X; Diederich J; Mounkoro P; Chevalier N; Ferster A; Van Schaftingen E; Veiga-da-Cunha M
J Inherit Metab Dis; 2022 Jul; 45(4):759-768. PubMed ID: 35506446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
